Biondo Investment Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$54.5M Sell
118,312
-1,079
-0.9% -$546K 6.99% 1
2025
Q4
$67.6M Sell
119,391
-2,790
-2% -$1.49M 8.18% 1
2025
Q3
$54.6M Sell
122,181
-592
-0.5% -$284K 6.84% 3
2025
Q2
$66.7M Sell
122,773
-1,366
-1% -$714K 8.8% 1
2025
Q1
$61.5M Sell
124,139
-2,076
-2% -$1.15M 8.73% 1
2024
Q4
$65.9M Sell
126,215
-4,523
-3% -$2.36M 9.08% 1
2024
Q3
$64.2M Sell
130,738
-2,632
-2% -$1.23M 8.8% 1
2024
Q2
$59.3M Buy
133,370
+60
+0% +$23.9K 8.78% 1
2024
Q1
$53.2M Sell
133,310
-2,593
-2% -$980K 8.23% 1
2023
Q4
$45.8M Sell
135,903
-1,105
-0.8% -$329K 7.79% 2
2023
Q3
$40M Sell
137,008
-386
-0.3% -$121K 7.54% 2
2023
Q2
$47M Sell
137,394
-1,778
-1% -$538K 8.68% 2
2023
Q1
$35.6M Sell
139,172
-1,318
-0.9% -$325K 7.19% 2
2022
Q4
$37.3M Sell
140,490
-1,290
-0.9% -$315K 8.3% 1
2022
Q3
$26.6M Sell
141,780
-760
-0.5% -$163K 6.13% 2
2022
Q2
$28.6M Buy
142,540
+6,091
+4% +$1.43M 6.3% 2
2022
Q1
$41.2M Sell
136,449
-1,919
-1% -$561K 7.25% 2
2021
Q4
$49.7M Sell
138,368
-290,995
-68% -$100M 8.29% 2
2021
Q3
$47.4M Buy
429,363
+286,896
+201% +$96.3M 8.14% 1
2021
Q2
$43.7M Sell
142,467
-864
-0.6% -$242K 7.5% 1
2021
Q1
$35.3M Sell
143,331
-5,070
-3% -$1.28M 7.03% 2
2020
Q4
$40.5M Sell
148,401
-84
-0.1% -$20.9K 7.76% 2
2020
Q3
$35.1M Buy
148,485
+8,274
+6% +$1.86M 7.61% 2
2020
Q2
$26.6M Sell
140,211
-8,958
-6% -$1.61M 6.72% 2
2020
Q1
$24.6M Sell
149,169
-41,058
-22% -$7.52M 8.16% 1
2019
Q4
$37.5M Sell
190,227
-5,313
-3% -$995K 8.65% 1
2019
Q3
$35.2M Sell
195,540
-8,946
-4% -$1.55M 8.99% 1
2019
Q2
$35.8M Buy
204,486
+825
+0.4% +$141K 8.48% 2
2019
Q1
$38.7M Sell
203,661
-1,965
-1% -$349K 9.72% 1
2018
Q4
$32.8M Sell
205,626
-21,720
-10% -$3.68M 9.91% 1
2018
Q3
$43.5M Buy
227,346
+3,213
+1% +$571K 10.33% 1
2018
Q2
$35.7M Sell
224,133
-8,502
-4% -$1.3M 9.02% 1
2018
Q1
$32M Sell
232,635
-15,993
-6% -$2.23M 8.34% 2
2017
Q4
$30.2M Sell
248,628
-545,118
-69% -$68.2M 7.64% 2
2017
Q3
$30.7M Buy
793,746
+522,999
+193% +$57M 8.46% 1
2017
Q2
$28.1M Sell
270,747
-23,121
-8% -$2.22M 8.14% 1
2017
Q1
$21.6M Buy
293,868
+26,298
+10% +$2.08M 7.71% 1
2016
Q4
$18.9M Sell
267,570
-24,894
-9% -$1.83M 6.24% 2
2016
Q3
$23.6M Sell
292,464
-1,809
-0.6% -$139K 7.97% 1
2016
Q2
$21.6M Sell
294,273
-3,231
-1% -$227K 7.72% 1
2016
Q1
$19.9M Buy
297,504
+11,565
+4% +$717K 7.53% 2
2015
Q4
$17.4M Sell
285,939
-3,123
-1% -$175K 5.76% 4
2015
Q3
$14.8M Sell
289,062
-1,422
-0.5% -$80.5K 4.91% 5
2015
Q2
$15.6M Sell
290,484
-4,608
-2% -$258K 4.69% 7
2015
Q1
$16.6M Sell
295,092
-945
-0.3% -$53.5K 4.91% 6
2014
Q4
$17.4M Buy
296,037
+11,313
+4% +$630K 5.23% 6
2014
Q3
$14.6M Buy
284,724
+11,790
+4% +$585K 4.49% 8
2014
Q2
$12.5M Sell
272,934
-5,886
-2% -$260K 3.94% 9
2014
Q1
$13.6M Sell
278,820
-8,001
-3% -$377K 4.5% 6
2013
Q4
$12.2M Buy
286,821
+5,481
+2% +$231K 4.18% 8
2013
Q3
$11.8M Sell
281,340
-3,780
-1% -$167K 4.46% 8
2013
Q2
$16M Buy
+285,120
New +$15.7M 6.95% 4

Other funds holding ISRG

Biondo Investment Advisors's ISRG Position: Q1 2026 in Review

Biondo Investment Advisors reduced its Intuitive Surgical (ISRG) stake by 0.9% in Q1 2026, selling an estimated $546K and leaving 118,312 shares worth $54.5M. The position accounts for 6.99% of the portfolio, ranked #1.

Biondo Investment Advisors first reported a position in ISRG in Q2 2013 and has held it in 52 quarters since. The position peaked at $67.6M in Q4 2025. 2,302 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Biondo Investment Advisors held 118,312 shares of Intuitive Surgical worth $54.5M as of Q1 2026.
  • Biondo Investment Advisors sold 1,079 Intuitive Surgical shares in Q1 2026, an estimated $546K.
  • Intuitive Surgical made up 6.99% of Biondo Investment Advisors's portfolio in Q1 2026, its #1 holding.
  • Biondo Investment Advisors first reported a position in Intuitive Surgical in Q2 2013 and has held it in 52 quarters since.
  • Biondo Investment Advisors's Intuitive Surgical position peaked at $67.6M in Q4 2025.
  • 2,302 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Biondo Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.